Developers of Oxford University-AstraZeneca COVID-19 Vaccine Report 70% Average Success
Developers of Oxford University-AstraZeneca COVID-19 Vaccine Report 70% Average Success
GALWAY, IRELAND--November 31, 2020--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--The COVID-19 vaccine under testing by Oxford University and AstraZeneca has reported a greater than expected average efficacy of 70%.
Within this article: Details positive test results, efficiency of vaccine, permission plans, expected production capacity, related vaccines success
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
